trial · primary record
Lucerastat
Fabry Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2029-03-15 |
| Primary endpoint | Change from baseline to Month 18 in kidney Gb3 BLISS score (average number of Gb3 inclusions per kidney peritubular capillary (PTC)). |
| Registry ID | NCT07778667 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:12.716Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07778667
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Lucerastat · compound